Lipid coating for medical devices delivering bioactive agent
View Patent ↗The present invention relates compositions for delivering therapeutic agents from a medical device including an expandable and collapsible structure and methods employing them. A lipid coating including one or more fatty acids increases the amount of therapeutic agent released from the device at the delivery site. The therapeutic agent can be in a matrix including a hydrophilic polymer or an amphiphilic polymer. Release and adhesion coatings can also facilitate delivery of therapeutic agent.
1. A medical device comprising:
a balloon,
a coating on all or a portion of the balloon, the coating comprising (i) nano- or microparticles that comprise a bioactive agent and (ii) a flexible hydrogel matrix, and
a lipid coating on the coating comprising the bioactive agent, the lipid coating having a melting or softening point greater than room temperature and less than body temperature of the subject and comprising a plurality of fatty acids;
the device being effective for delivering the bioactive agent to a site within a subject.
2. The device of claim 1 , wherein the lipid coating comprises two fatty acids.
3. The device of claim 1 , wherein the plurality of fatty acids is a mixture of fatty acids that are solid at room temperature and soft or liquid at body temperature of the subject.
4. The device of claim 1 , wherein the plurality of fatty acids is a mixture of fatty acids that comprises oleic acid, dodecanoic acid, or salt thereof.
5. The device of claim 1 , wherein the fatty acids comprise:
a saturated fatty acid of formula: CH 3 (CH 2 ) n COOH, where n is an integer in the range of 4 to 20; and
an unsaturated fatty acid of formula: CH 3 (CH 2 ) m C═C(CH 2 ) o COOH, where m and o are independently integer in the range of 2 to 20; or
salts thereof.
6. The device of claim 1 , wherein the balloon is an angioplasty balloon.
7. The device of claim 1 , wherein the bioactive agent comprises an antiproliferative agent, an antiinflamatory agent, or an antiplatelet agent.
8. The device of claim 7 , wherein the bioactive agent comprises paclitaxel.
9. The device of claim 1 , wherein a majority of the nano- or microparticles are non-homogenously distributed in the flexible hydrogel matrix, and partially embedded in the flexible hydrogel matrix at its surface.
10. The device of claim 1 , wherein the nano- or microparticles consist of the therapeutic agent.
11. The device of claim 1 , wherein about 10% to 100% of the nano- or microparticles associated with the balloon or coating are released from the device upon expansion of the balloon.
12. The device of claim 1 , wherein the coating comprising the flexible hydrogel matrix comprises a hydrogel polymer selected from the group consisting of poly(acrylamide), poly(methacrylamide), poly(vinylpyrrolidone), poly(acrylic acid), poly(ethylene glycol), poly(vinyl alcohol), poly(HEMA), methyl vinyl ether/maleic anhydride copolymers, vinyl pyrrolidone/(meth)acrylamide copolymers, and mixture thereof.
13. The device of claim 1 , wherein the coating comprising the flexible hydrogel matrix comprises a polymer comprising pendent reacted photogroups that covalently bond the polymer to other polymers in the coating or to a surface of the expandable and collapsible structure.
14. The device of claim 1 , wherein the coating comprising the bioactive agent has a thickness of about 5 μm to about 100 μm.
15. The device of claim 1 , wherein the nano- or microparticles have an average greatest dimension of about 0.1 μm to about 10 μm.
16. A method of delivering a bioactive agent to a site in a subject, the method comprising:
providing the medical device of claim 1 at a site in a subject; and
expanding the balloon at the site in the subject to contact a tissue at the site with the coating comprising the bioactive agent and the lipid coating and to release bioactive agent to the tissue.
17. The device of claim 1 , wherein the melting point is in the range of 25° C. to 37° C.